Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients

doi:10.4239/wjd.v8.i3.112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

(446)

(369)

(0)

(6721)

(9)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Prospective Study

World J Diabetes. Mar 15, 2017; 8(3): 112-119
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.112

Table 6 Genotypic distribution of responders and non-responders having micro-/ macro-albuminuria

Gene	Genotype (n = 252)	Micro-albuminuric group (n = 170)			Macro-albuminuric group (n = 82)
		R (%) (n = 76)	NR (%) (n = 94)	P-value¹	Rc (%) (n = 45)	NR (%) (n = 37)	P-value²
ACE (I/D)	II	23 (45)	28 (55)	0.974	15 (56)	12 (44)	0.636
	ID	42 (44)	53 (56)		20 (53)	18 (47)
	DD	11 (49)	13 (54)		10 (59)	7 (41)
AGT (M235T)	MM	25 (60)	17 (40)	0.11	9 (47)	10 (53)	0.201
	MT	36 (40)	53 (60)		23 (51)	22 (49)
	TT	15 (38)	24 (62)		13 (72)	5 (28)

¹P > 0.05: Comparison between responders and non-responders to therapy in micro-albuminuric group;

²P > 0.05: Comparison between responders and non-responders to therapy in macro-albuminuric group. ACE: Angiotensin converting enzyme; AGT: Angiotensinogen; R: Responders; NR: Non-responders.

Full Size Table

Citation: Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/112.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i3.112

Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119 [PMID: 28344754 DOI: 10.4239/wjd.v8.i3.112]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.